Adjunctive short- and long-term combination treatment of esketamine and VNS in difficult to treat depression (DTD)
Introduction NMDA-Receptor antagonists have rapid antidepressant and antisuicidal properties. However, the antidepressant effect is short lasting raising the question of best maintenance strategy, which is unanswered so far. Invasive vagus nerve stimulation (VNS) as a treatment option for refractor...
Main Authors: | E. Kavakbasi, B. T. Baune |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823005722/type/journal_article |
Similar Items
-
Impact of Adjunctive VNS on Drug Load, Depression Severity, and Number of Neuromodulatory Maintenance Treatments
by: Erhan Kavakbasi, et al.
Published: (2024-02-01) -
Impact of invasive VNS on depression severity and the need of concomitant drug and neuromodulatory treatment dose
by: E. Kavakbasi, et al.
Published: (2022-06-01) -
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports
by: Matteo Marcatili, et al.
Published: (2022-09-01) -
Overcoming the myths of esketamine administration: different and not difficult
by: Florian Buchmayer, et al.
Published: (2023-11-01) -
Description of the computer code 2DTD
by: Shober, Robert Anthony
Published: (2014)